Subscribe To
Annexon Highlights Recent Pipeline and Business Progress and Reports Second Quarter 2023 Financial Results
ARCHER Trial Results Presented at ASRS Further Demonstrate Preservation of Visual Function in Patients with Geographic Atrophy; Company to Engage Regulatory Agencies to Determine Optimal Path Forward Multiple Key Catalysts Expected in Second Half 2023, Including Completion of Enrollment in the Phase 3 Pivotal Trial of ANX005 in GBS and Phase 1 Data from ANX1502 […] The post Annexon Highlights Recent Pipeline and Business Progress and Reports Second Quarter 2023 Financial Results appeared first o...
Read More
Posted: Aug 7 2023, 10:30
Author Name: forextv
Views: 022259